niflumic acid has been researched along with quinoxalines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyal, RK; He, XD | 1 |
| Paterson, WG; Zhang, Y | 1 |
2 other study(ies) available for niflumic acid and quinoxalines
| Article | Year |
|---|---|
Evidence for NO. redox form of nitric oxide as nitrergic inhibitory neurotransmitter in gut.
Topics: Aminoquinolines; Animals; Apamin; Chloride Channels; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Guinea Pigs; Ileum; In Vitro Techniques; Muscle, Smooth; Neuromuscular Junction; Neurotransmitter Agents; Niflumic Acid; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; ortho-Aminobenzoates; Oxadiazoles; Oxidation-Reduction; Potassium Channel Blockers; Quinoxalines | 1998 |
Role of sarcoplasmic reticulum in control of membrane potential and nitrergic response in opossum lower esophageal sphincter.
Topics: Animals; Anthracenes; Atropine; Azepines; Caffeine; Calcium; Chloride Channels; Enzyme Inhibitors; Esophagogastric Junction; Female; Guanethidine; In Vitro Techniques; Indoles; Male; Membrane Potentials; Muscle, Smooth; Myosin-Light-Chain Kinase; Nifedipine; Niflumic Acid; Nitric Oxide; Opossums; Oxadiazoles; Quinoxalines; Ryanodine; Sarcoplasmic Reticulum; Substance P; Tetraethylammonium | 2003 |